» Articles » PMID: 39548054

Succinylation Modification-mediated Upregulation of Sp1 Promotes Hepatocellular Carcinoma Cell Proliferation

Overview
Journal Discov Oncol
Publisher Springer
Specialty Oncology
Date 2024 Nov 15
PMID 39548054
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) remains one of the most prevalent malignant tumors globally, characterized by high incidence and mortality rates. Despite ongoing research, the underlying molecular mechanisms of HCC development are not yet fully understood. Utilizing bioinformatic analysis, real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR), and Western blot assays, we identified that the expression of specificity protein 1 (Sp1) was significantly elevated in HCC cells compared to normal cells. Knockdown of the Sp1 gene led to a marked reduction in the viability and clonogenic potential of HCC cells. Further investigation revealed that the succinylation level of Sp1 was also increased in HCC cells. The upregulation of Sp1 expression was attributed to its succinylation, mediated by KAT2A, with lysine (K)562 identified as the succinylation site. Additionally, KAT2A and Sp1 were found to influence the upregulation of mTOR phosphorylation. Collectively, these findings suggest that KAT2A-promoted succinylation of Sp1 enhances the proliferative capacity of HCC cells by activating the mTOR pathway, providing a theoretical foundation for potential therapeutic strategies against HCC.

References
1.
Kumar S, Lombard D . Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology. Crit Rev Biochem Mol Biol. 2018; 53(3):311-334. PMC: 6233320. DOI: 10.1080/10409238.2018.1458071. View

2.
Kaczynski J, Cook T, Urrutia R . Sp1- and Krüppel-like transcription factors. Genome Biol. 2003; 4(2):206. PMC: 151296. DOI: 10.1186/gb-2003-4-2-206. View

3.
Liu X, Chen R, Liu L . SP1-DLEU1-miR-4429 feedback loop promotes cell proliferative and anti-apoptotic abilities in human glioblastoma. Biosci Rep. 2019; 39(12). PMC: 6900472. DOI: 10.1042/BSR20190994. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y . Targeting mTOR for cancer therapy. J Hematol Oncol. 2019; 12(1):71. PMC: 6612215. DOI: 10.1186/s13045-019-0754-1. View